Cargando…

Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data

BACKGROUND: The investigation of the prevalence of the IgG and the IgM isotypes of anticardiolipin (aCL) and antib2glycoprotein I (ab2gpI) Abs in healthy Serbian middleaged subjects was the main goal of our study. In addition, we analyzed the potential associations of above-mentioned Abs with serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Bećarević, Mirjana B., Jovičić, Snežana, Ignjatović, Svetlana D., Mirković, Duško
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618332/
https://www.ncbi.nlm.nih.gov/pubmed/36381077
http://dx.doi.org/10.5937/jomb0-35642
_version_ 1784821027073687552
author Bećarević, Mirjana B.
Jovičić, Snežana
Ignjatović, Svetlana D.
Mirković, Duško
author_facet Bećarević, Mirjana B.
Jovičić, Snežana
Ignjatović, Svetlana D.
Mirković, Duško
author_sort Bećarević, Mirjana B.
collection PubMed
description BACKGROUND: The investigation of the prevalence of the IgG and the IgM isotypes of anticardiolipin (aCL) and antib2glycoprotein I (ab2gpI) Abs in healthy Serbian middleaged subjects was the main goal of our study. In addition, we analyzed the potential associations of above-mentioned Abs with serum proteins and lipids/lipoproteins. METHODS: Forty healthy subjects were included in our study. Obesity (BMI 30 kg/m2) was present in 8/40 (20%) subjects. Titers of analyzed Abs were measured by ELISA. RESULTS: The prevalence of IgG and IgM ab2gpI Abs was 5% and 12.5%, respectively, while the prevalence of IgM aCL was 10%. The IgG ab2gpI Abs were significantly different between subjects with normal triglycerides levels and those with hypertriglyceridemia (Mann-Whitney, P = 0.014). The significant difference in hsCRP concentrations was observed between subjects with the increased levels of the IgM isotype of aCL Abs and those with normal IgM aCL values (Mann-Whitney, P = 0.028). CONCLUSIONS: Dyslipidemia and BMI ≥30 were associated with aPL Abs and therefore, the correction of BMI and lipid status might be beneficial in reduction or elimination of predisposing factors that might trigger thrombotic events in otherwise healthy middle-aged subjects. Larger national study is necessary to confirm our findings.
format Online
Article
Text
id pubmed-9618332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format MEDLINE/PubMed
spelling pubmed-96183322022-11-14 Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data Bećarević, Mirjana B. Jovičić, Snežana Ignjatović, Svetlana D. Mirković, Duško J Med Biochem Original Paper BACKGROUND: The investigation of the prevalence of the IgG and the IgM isotypes of anticardiolipin (aCL) and antib2glycoprotein I (ab2gpI) Abs in healthy Serbian middleaged subjects was the main goal of our study. In addition, we analyzed the potential associations of above-mentioned Abs with serum proteins and lipids/lipoproteins. METHODS: Forty healthy subjects were included in our study. Obesity (BMI 30 kg/m2) was present in 8/40 (20%) subjects. Titers of analyzed Abs were measured by ELISA. RESULTS: The prevalence of IgG and IgM ab2gpI Abs was 5% and 12.5%, respectively, while the prevalence of IgM aCL was 10%. The IgG ab2gpI Abs were significantly different between subjects with normal triglycerides levels and those with hypertriglyceridemia (Mann-Whitney, P = 0.014). The significant difference in hsCRP concentrations was observed between subjects with the increased levels of the IgM isotype of aCL Abs and those with normal IgM aCL values (Mann-Whitney, P = 0.028). CONCLUSIONS: Dyslipidemia and BMI ≥30 were associated with aPL Abs and therefore, the correction of BMI and lipid status might be beneficial in reduction or elimination of predisposing factors that might trigger thrombotic events in otherwise healthy middle-aged subjects. Larger national study is necessary to confirm our findings. Society of Medical Biochemists of Serbia, Belgrade 2022-10-15 2022-10-15 /pmc/articles/PMC9618332/ /pubmed/36381077 http://dx.doi.org/10.5937/jomb0-35642 Text en 2022 Mirjana B. Bećarević, Snežana Jovičić, Svetlana D. Ignjatović, Duško Mirković, published by CEON/CEES https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License.
spellingShingle Original Paper
Bećarević, Mirjana B.
Jovičić, Snežana
Ignjatović, Svetlana D.
Mirković, Duško
Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
title Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
title_full Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
title_fullStr Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
title_full_unstemmed Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
title_short Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data
title_sort antiphospholipid antibodies in healthy serbian middle-aged subjects: preliminary data
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618332/
https://www.ncbi.nlm.nih.gov/pubmed/36381077
http://dx.doi.org/10.5937/jomb0-35642
work_keys_str_mv AT becarevicmirjanab antiphospholipidantibodiesinhealthyserbianmiddleagedsubjectspreliminarydata
AT jovicicsnezana antiphospholipidantibodiesinhealthyserbianmiddleagedsubjectspreliminarydata
AT ignjatovicsvetlanad antiphospholipidantibodiesinhealthyserbianmiddleagedsubjectspreliminarydata
AT mirkovicdusko antiphospholipidantibodiesinhealthyserbianmiddleagedsubjectspreliminarydata